Cargando…
Developmental priming of cancer susceptibility
DNA mutations are necessary drivers of cancer, yet only a small subset of mutated cells go on to cause the disease. To date, the mechanisms that determine which rare subset of cells transform and initiate tumorigenesis remain unclear. Here, we take advantage of a unique model of intrinsic developmen...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515831/ https://www.ncbi.nlm.nih.gov/pubmed/37745326 http://dx.doi.org/10.1101/2023.09.12.557446 |
_version_ | 1785109027360866304 |
---|---|
author | Panzeri, Ilaria Fagnocchi, Luca Apostle, Stefanos Tompkins, Megan Wolfrum, Emily Madaj, Zachary Hostetter, Galen Liu, Yanqing Schaefer, Kristen Chih-Hsiang, Yang Bergsma, Alexis Drougard, Anne Dror, Erez Chandler, Darrell Schramek, Daniel Triche, Timothy J. Pospisilik, J. Andrew |
author_facet | Panzeri, Ilaria Fagnocchi, Luca Apostle, Stefanos Tompkins, Megan Wolfrum, Emily Madaj, Zachary Hostetter, Galen Liu, Yanqing Schaefer, Kristen Chih-Hsiang, Yang Bergsma, Alexis Drougard, Anne Dror, Erez Chandler, Darrell Schramek, Daniel Triche, Timothy J. Pospisilik, J. Andrew |
author_sort | Panzeri, Ilaria |
collection | PubMed |
description | DNA mutations are necessary drivers of cancer, yet only a small subset of mutated cells go on to cause the disease. To date, the mechanisms that determine which rare subset of cells transform and initiate tumorigenesis remain unclear. Here, we take advantage of a unique model of intrinsic developmental heterogeneity (Trim28(+/D9)) and demonstrate that stochastic early life epigenetic variation can trigger distinct cancer-susceptibility ‘states’ in adulthood. We show that these developmentally primed states are characterized by differential methylation patterns at typically silenced heterochromatin, and that these epigenetic signatures are detectable as early as 10 days of age. The differentially methylated loci are enriched for genes with known oncogenic potential. These same genes are frequently mutated in human cancers, and their dysregulation correlates with poor prognosis. These results provide proof-of-concept that intrinsic developmental heterogeneity can prime individual, life-long cancer risk. |
format | Online Article Text |
id | pubmed-10515831 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cold Spring Harbor Laboratory |
record_format | MEDLINE/PubMed |
spelling | pubmed-105158312023-09-23 Developmental priming of cancer susceptibility Panzeri, Ilaria Fagnocchi, Luca Apostle, Stefanos Tompkins, Megan Wolfrum, Emily Madaj, Zachary Hostetter, Galen Liu, Yanqing Schaefer, Kristen Chih-Hsiang, Yang Bergsma, Alexis Drougard, Anne Dror, Erez Chandler, Darrell Schramek, Daniel Triche, Timothy J. Pospisilik, J. Andrew bioRxiv Article DNA mutations are necessary drivers of cancer, yet only a small subset of mutated cells go on to cause the disease. To date, the mechanisms that determine which rare subset of cells transform and initiate tumorigenesis remain unclear. Here, we take advantage of a unique model of intrinsic developmental heterogeneity (Trim28(+/D9)) and demonstrate that stochastic early life epigenetic variation can trigger distinct cancer-susceptibility ‘states’ in adulthood. We show that these developmentally primed states are characterized by differential methylation patterns at typically silenced heterochromatin, and that these epigenetic signatures are detectable as early as 10 days of age. The differentially methylated loci are enriched for genes with known oncogenic potential. These same genes are frequently mutated in human cancers, and their dysregulation correlates with poor prognosis. These results provide proof-of-concept that intrinsic developmental heterogeneity can prime individual, life-long cancer risk. Cold Spring Harbor Laboratory 2023-09-15 /pmc/articles/PMC10515831/ /pubmed/37745326 http://dx.doi.org/10.1101/2023.09.12.557446 Text en https://creativecommons.org/licenses/by-nd/4.0/This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nd/4.0/) , which allows reusers to copy and distribute the material in any medium or format in unadapted form only, and only so long as attribution is given to the creator. The license allows for commercial use. |
spellingShingle | Article Panzeri, Ilaria Fagnocchi, Luca Apostle, Stefanos Tompkins, Megan Wolfrum, Emily Madaj, Zachary Hostetter, Galen Liu, Yanqing Schaefer, Kristen Chih-Hsiang, Yang Bergsma, Alexis Drougard, Anne Dror, Erez Chandler, Darrell Schramek, Daniel Triche, Timothy J. Pospisilik, J. Andrew Developmental priming of cancer susceptibility |
title | Developmental priming of cancer susceptibility |
title_full | Developmental priming of cancer susceptibility |
title_fullStr | Developmental priming of cancer susceptibility |
title_full_unstemmed | Developmental priming of cancer susceptibility |
title_short | Developmental priming of cancer susceptibility |
title_sort | developmental priming of cancer susceptibility |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515831/ https://www.ncbi.nlm.nih.gov/pubmed/37745326 http://dx.doi.org/10.1101/2023.09.12.557446 |
work_keys_str_mv | AT panzeriilaria developmentalprimingofcancersusceptibility AT fagnocchiluca developmentalprimingofcancersusceptibility AT apostlestefanos developmentalprimingofcancersusceptibility AT tompkinsmegan developmentalprimingofcancersusceptibility AT wolfrumemily developmentalprimingofcancersusceptibility AT madajzachary developmentalprimingofcancersusceptibility AT hostettergalen developmentalprimingofcancersusceptibility AT liuyanqing developmentalprimingofcancersusceptibility AT schaeferkristen developmentalprimingofcancersusceptibility AT chihhsiangyang developmentalprimingofcancersusceptibility AT bergsmaalexis developmentalprimingofcancersusceptibility AT drougardanne developmentalprimingofcancersusceptibility AT drorerez developmentalprimingofcancersusceptibility AT developmentalprimingofcancersusceptibility AT chandlerdarrell developmentalprimingofcancersusceptibility AT schramekdaniel developmentalprimingofcancersusceptibility AT trichetimothyj developmentalprimingofcancersusceptibility AT pospisilikjandrew developmentalprimingofcancersusceptibility |